Patents by Inventor Peter Liang

Peter Liang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant chimeric bovine/human parainfluenza virus 3 expressing rsv g and its use
    Patent number: 11975063
    Abstract: Recombinant chimeric bovine/human parainfluenza virus 3 (rB/HPIV3) vectors expressing Respiratory Syncytial Virus (RSV) G protein or a recombinant RSV G protein, as well as methods of their use and manufacture, are provided. The rB/HPIV3 vector comprises a genome comprising a heterologous gene encoding the RSV G protein or the recombinant RSV G protein. Nucleic acid molecules comprising the sequence of the genome or antigenome of the disclosed rB/HPIV3 vectors are also provided. The disclosed rB/HPIV3 vectors can be used, for example, to induce an immune response to RSV and HPIV3 in a subject.
    Type: Grant
    Filed: February 1, 2022
    Date of Patent: May 7, 2024
    Assignee: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services
    Inventors: Peter L. Collins, Ursula J. Buchholz, Bo Liang, Shirin Munir
  • INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS LIPOAMIDE DEHYDROGENASE
    Publication number: 20240132480
    Abstract: Disclosed are compounds for inhibiting lipoamide dehydrogenase (Lpd), and methods of treating tuberculosis.
    Type: Application
    Filed: January 7, 2022
    Publication date: April 25, 2024
    Inventors: John Ginn, Shan SUN, Mayako Michino, Nigel Liverton, Rui Liang, Peter T. Meinke, David Huggins, Ruslana Bryk, Carl F. Nathan
  • ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
    Publication number: 20240122059
    Abstract: A compound of Formula I, is provided. In Formula I, one of Z1, Z2, and Z3 is N and the remainder are C; each of L1 and L2 is independently selected from a direct bond and a linking group; at least one of R1, R2, RA, RB, RC, RD, and RE comprises a group R* having a structure selected form the group consisting of Formula II, -Q(R3)(R4)a(R5)b, Formula III, and Formula IV, Each R, R?, R?, R1, R2, R3, R4, R5, RA, RB, RC, RD, RE, RF, RG, and RH is independently hydrogen or a General Substituent, with the proviso that group R* is not adamantyl. Formulations, OLEDs, and consumer products containing the compound are also provided.
    Type: Application
    Filed: September 27, 2023
    Publication date: April 11, 2024
    Applicant: UNIVERSAL DISPLAY CORPORATION
    Inventors: Hsiao-Fan CHEN, Geza SZIGETHY, Rasha HAMZE, Nicholas J. THOMPSON, Hojae CHOI, Weiye GUAN, Raghupathi NEELARAPU, Charles J. STANTON, Douglas WILLIAMS, Ving Jick LEE, Joseph A. MACOR, Dmitry ANDRIANOV, Chao LIANG, Steven Kit CHOW, Tyler FLEETHAM, Peter WOLOHAN, Morgan C. MACINNIS
  • LOW-BORON, BARIUM-FREE, ALKALINE EARTH ALUMINOSILICATE GLASS AND ITS APPLICATIONS
    Publication number: 20180319700
    Abstract: A low-boron, barium-free, alkaline earth alumino-silicate glass composition having a low content of B2O3, high content of Al2O3, and a controlled ratio of (B2O3+CaO+MgO+SrO)/Al2O3. The glass composition may be suitable for low temperature poly-Si thin film transistors on substrates having a high glass strain point temperature.
    Type: Application
    Filed: December 1, 2015
    Publication date: November 8, 2018
    Inventors: Jack Y. Ding, Peter Liang
  • GLASS COMPOSITION FOR CHEMICALLY STRENGTHENED ALKALI-ALUMINOSILICATE GLASS AND METHOD FOR THE MANUFACTURE THEREOF
    Publication number: 20180194669
    Abstract: A glass composition for producing chemically strengthened alkali-aluminosilicate glass and a method for manufacturing the chemically strengthened alkali-aluminosilicate glass. The chemically strengthened alkali-aluminosilicate glass is suitable for use as high-strength cover glass for touch displays, solar cell cover glass and laminated safety glass.
    Type: Application
    Filed: June 23, 2015
    Publication date: July 12, 2018
    Inventors: Jack Y. Ding, Cherry Chen, Peter Liang, David Chang